ecancermedicalscience · 2018 · 19 citations · 40 references
MedicineOncologyCancer EpidemiologyClinical EpidemiologyEpidemiologyCancer MortalityCancer Survival AnalysisComorbid Medical ConditionsComorbidityComorbidity AssessmentMedical ComorbiditiesCharlson Comorbidity IndexComorbidity AnalysisComorbidity IndicesComorbidity Measurement MethodologyComorbidity PrevalenceComorbidity PrognosisMortality RatesSurvival Rates
PURPOSE: Comorbidities have been indicated to influence cancer care and outcome, with strong associations between the presence of comorbidities and patient survival. The objective of this study is to determine the magnitude and pattern of comorbidities in Nigerian cancer populations, and demonstrate the use of comorbidity indices in predicting mortality/survival rates of cancer patients. METHODS: Using a retrospective study design, data were extracted from hospital reports of patients presenting for oncology care between January 2015 and December 2016 at two tertiary health facilities in Lagos, Nigeria. Patient comorbidities were ranked and weighted using the Charlson comorbidity index (CCI). RESULTS: < 0.05). CONCLUSION: Comorbidities occur significantly in Nigerian cancer patients and influence the prognosis, treatment outcome and survival rates of these patients. There is a need to routinely evaluate cancer patients for comorbidities with the aim of instituting appropriate multidisciplinary management measures where necessary.
40
Validation of a combined comorbidity index
Mary E. Charlson, Ted P. Szatrowski, Janey C. Peterson et al. · Journal of Clinical Epidemiology · 1994 · 6.6K citations
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray, Jiansong Ren, E. Masuyer et al. · International Journal of Cancer · 2012 · 1.9K citations · Full text
Brenda K. Edwards, Anne‐Michelle Noone, Angela B. Mariotto et al. · Cancer · 2013 · 1.3K citations · Full text